Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

SAB Biotherapeutics (SABS) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for SAB Biotherapeutics (SABS) over the last 5 years, with Q3 2025 value amounting to 0.0.

  • SAB Biotherapeutics' Asset Utilization Ratio fell 10223.81% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year decrease of 10223.81%. This contributed to the annual value of 0.02 for FY2024, which is 3784.46% down from last year.
  • Per SAB Biotherapeutics' latest filing, its Asset Utilization Ratio stood at 0.0 for Q3 2025, which was down 10223.81% from 0.0 recorded in Q2 2025.
  • In the past 5 years, SAB Biotherapeutics' Asset Utilization Ratio ranged from a high of 0.75 in Q1 2022 and a low of 0.0 during Q3 2025
  • For the 5-year period, SAB Biotherapeutics' Asset Utilization Ratio averaged around 0.25, with its median value being 0.13 (2023).
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first soared by 3768.06% in 2022, then crashed by 10223.81% in 2025.
  • Over the past 5 years, SAB Biotherapeutics' Asset Utilization Ratio (Quarter) stood at 0.61 in 2021, then fell by 24.79% to 0.46 in 2022, then crashed by 91.37% to 0.04 in 2023, then crashed by 32.33% to 0.03 in 2024, then tumbled by 102.17% to 0.0 in 2025.
  • Its last three reported values are 0.0 in Q3 2025, 0.0 for Q2 2025, and 0.01 during Q1 2025.